3D Bioprinting Core Facility

The 3D Bioprinting Core Facility is dedicated to advancing biomedical research through cutting-edge 3D bioprinting and nanoprinting technologies. Our mission is to replicate the intricate architecture of human tissues and tumors in three dimensions.

Our platform enables the creation of highly realistic tissue models that serve as powerful tools for drug screening and toxicity testing – offering a more ethical, cost-effective alternative to traditional animal models. This not only accelerates the drug development pipeline but also aligns with global regulatory and ethical shifts toward reducing animal testing.

Looking ahead, our work paves the way for transformative applications in personalized medicine. By generating patient-specific tissue models, we enable the development and testing of therapies tailored to an individual’s genetic profile – particularly in oncology, where precision is critical. Furthermore, our long-term vision includes the production of functional tissue substitutes for regenerative medicine and transplantation.

We are actively seeking collaborators from academia, clinics & industry. Key areas for collaboration include:

• Pharmaceutical & Biotech Co-Development: Partner with us to co-develop and validate tissue models for preclinical drug screening.
• Personalized Medicine Platforms: Collaborate on patient-specific tissue constructs to support precision oncology and individualized treatment strategies.
• Technology Integration: Integrate our bioprinting and nanoprinting capabilities with your specific project needs.

Further information on ours services here:  Service – 3D Biodruck Core Facility